Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With ABC-DLBCL

Although ibrutinib adds to the cost of treatment, its benefits over the long term justify the cost, investigators found.

Related Keywords

Phoenix ,Arizona ,United States , ,Image Credit ,Ibrutinib ,R Chop ,Abc Dlbcl ,Btk Inhibitor ,I Rchop ,